Chipinda Itai, Anderson Stacey E, Butterworth Leon F, Beezhold Donald, Siegel Paul D
Allergy and Clinical Immunology Branch, Health Effects Laboratory Division, National Institute for Occupational Safety and Health, 1095 Willowdale Road, Morgantown, WV 26505-2888, United States.
Toxicology. 2009 Mar 29;257(3):113-6. doi: 10.1016/j.tox.2008.12.019. Epub 2008 Dec 30.
The local lymph node assay (LLNA) is widely used to identify chemicals that are contact sensitizers. The assay involves dosing mice with the chemical on both ears and pooling the superficial parotid lymph nodes for assessment of lymphocyte proliferation as a marker of sensitization. The present study explored potential reduction in animal usage by dosing one ear with the allergen and the other with vehicle-only. The respective draining lymph nodes were processed separately for tritiated thymidine ((3)H-TdR) incorporation. Cell proliferation in proper axillary and renal nodes, as well as in the spleen was also assessed. Cross-contamination of the chemicals from the dosed ears to other parts of the body via preening was prevented by dosing restrained animals and washing off the residual chemical with saline after 4h. Dosing the left ear with 0.02% oxazolone (OX) on unrestrained animals resulted in marked cell proliferation in its draining lymph node (stimulation index, SI=12.8) and in the lymph node draining the contra-lateral vehicle-dosed ear (SI=6), as well as the proper axillary lymph nodes (SI=3.3). Increased (3)H-TdR incorporation was not observed in the renal lymph nodes (SI=1.1). Similar stimulation of cells was observed in the lymph node draining the ear contra-lateral to the 30% hexylcinnamaldehyde (HCA)-dosed ear. Increased proliferative activity was observed in contra-lateral draining lymph nodes of restrained mice demonstrating that these results cannot be attributed to cross-contamination of adjacent skin. A significant increase in proliferation of splenocytes was also observed. It is concluded that dermal application of a contact allergen, as exemplified by OX and HCA, may induce cell proliferation in the neighboring lymph nodes and spleen indicative of hapten and/or haptenated proteins diffusing through the skin to peripheral nodes and the blood to produce systemic sensitization. It is also possible that lymphatic capillaries may communicate between the left and right side of the mouse head. Thus the contra-lateral draining superficial parotid node cannot be used as a control for application of contact allergen to a single ear in a modified LLNA.
局部淋巴结试验(LLNA)被广泛用于识别接触性致敏剂。该试验包括给小鼠双耳涂抹受试化学品,并收集浅表腮腺淋巴结以评估淋巴细胞增殖,作为致敏的标志物。本研究探讨了通过给一只耳朵涂抹过敏原,另一只耳朵仅涂抹赋形剂来减少动物使用量的可能性。分别处理各自引流的淋巴结以检测氚化胸腺嘧啶核苷(³H-TdR)掺入情况。还评估了腋下和肾周淋巴结以及脾脏中的细胞增殖情况。通过给受限制的动物给药,并在4小时后用生理盐水冲洗残留化学品,防止了受试化学品从给药耳朵通过梳理毛发交叉污染到身体其他部位。给未受限制的动物左耳涂抹0.02%恶唑酮(OX),导致其引流淋巴结出现明显的细胞增殖(刺激指数,SI = 12.8),对侧涂抹赋形剂耳朵的引流淋巴结也出现细胞增殖(SI = 6),以及腋下淋巴结(SI = 3.3)。在肾周淋巴结中未观察到³H-TdR掺入增加(SI = 1.1)。在涂抹30%己基肉桂醛(HCA)耳朵对侧的引流淋巴结中观察到类似的细胞刺激。在受限制小鼠的对侧引流淋巴结中观察到增殖活性增加,表明这些结果不能归因于相邻皮肤的交叉污染。在脾细胞中也观察到增殖显著增加。得出的结论是,以OX和HCA为例,皮肤涂抹接触性过敏原可能会诱导邻近淋巴结和脾脏中的细胞增殖,这表明半抗原和/或半抗原化蛋白通过皮肤扩散到外周淋巴结和血液中,从而产生全身致敏。也有可能是淋巴管在小鼠头部的左右两侧之间相通。因此,在改良的LLNA中,对侧引流的浅表腮腺淋巴结不能用作单耳涂抹接触性过敏原的对照。